Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL Journal Article


Authors: Hanash, A. M.; Kappel, L. W.; Yim, N. L.; Nejat, R. A.; Goldberg, G. L.; Smith, O. M.; Rao, U. K.; Dykstra, L.; Na, I. K.; Holland, A. M.; Dudakov, J. A.; Liu, C.; Murphy, G. F.; Leonard, W. J.; Heller, G.; van den Brink, M. R. M.
Article Title: Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL
Abstract: IL-21 is a proinflammatory cytokine produced by Th17 cells. Abrogation of IL-21 signaling has recently been shown to reduce GVHD while retaining graft-versus-leukemia/lymphoma (GVL) responses. However, the mechanisms by which IL-21 may lead to a separation of GVHD and GVL remain incompletely understood. In a murine MHC-mismatched BM transplantation model, we observed that IL-21 receptor knockout (IL-21R KO) donor T cells mediate decreased systemic and gastrointestinal GVHD in recipients of a transplant. This reduction in GVHD was associated with expansion of transplanted donor regulatory T cells and with tissue-specific modulation of Th-cell function. IL-21R KO and wild-type donor T cells showed equivalent alloactivation, but IL-21R KO T cells showed decreased infiltration and inflammatory cytokine production within the mesenteric lymph nodes. However, Th-cell cytokine production was maintained peripherally, and IL-21R KO T cells mediated equivalent immunity against A20 and P815 hematopoietic tumors. In summary, abrogation of IL-21 signaling in donor T cells leads to tissue-specific modulation of immunity, such that gastrointestinal GVHD is reduced, but peripheral T-cell function and GVL capacity are retained. IL-21 is thus an exciting target for therapeutic intervention and improvement of clinical transplantation outcomes.
Journal Title: Blood
Volume: 118
Issue: 2
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2011-07-14
Start Page: 446
End Page: 455
Language: English
DOI: 10.1182/blood-2010-07-294785
PROVIDER: scopus
PMCID: PMC3138694
PUBMED: 21596854
DOI/URL:
Notes: --- - "Export Date: 17 August 2011" - "CODEN: BLOOA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Glenn Heller
    399 Heller
  2. Il-Kang Na
    27 Na
  3. Alan M Hanash
    119 Hanash
  4. Jarrod Andrew Dudakov
    58 Dudakov
  5. Odette Marsinay Smith
    98 Smith
  6. Uttam Keshav Rao
    31 Rao
  7. Nury Yim
    28 Yim
  8. Amanda M Holland
    55 Holland
  9. Lucy Willis
    28 Willis
  10. Rebecca Ajodan
    3 Ajodan